ABT 102

CAS : 808756-71-0

Ref. 3D-IHB75671

Informations sur le produit

• Nom: ABT 102
• Synonymes: 1-[(1R)-5-tert-Butyl-2,3-dihydro-1H-inden-1-yl]-3-(1H-indazol-4-yl)urea, N-(5-tert-Butylindan-4-yl)-N′-(1H-indazol-4-yl)-urea, N-[(1R)-5-(1,1-Dimethylethyl)-2,3-dihydro-1H-inden-1-yl]-N′-1H-indazol-4-ylurea, Urea, N-[(1R)-5-(1,1-dimethylethyl)-2,3-dihydro-1H-inden-1-yl]-N′-1H-indazol-4-yl-

Description

ABT 102 is a water-soluble drug that belongs to the class of compounds. It has a particle size of less than 10 microns and is soluble in water. ABT 102 is able to bind to benzyl groups and form solid dispersions. This drug potently inhibits receptor activity in vitro, as shown by its ability to inhibit the binding of ligands to their corresponding receptors in a dose-dependent manner. In vivo experiments have shown that ABT 102 has potential clinical efficacy against bone cancer. The linear regression analysis of data from human trials shows that there is a statistically significant correlation between plasma concentration and receptor occupancy for ABT 102. Hydrogen bond interactions with cation channels may be responsible for the observed increase in plasma concentration following oral administration.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 348.4 g/mol
• Formule: C₂₁H₂₄N₄O
• Degré de pureté: Min. 95%